Yasu Morita to Febrile Neutropenia
This is a "connection" page, showing publications Yasu Morita has written about Febrile Neutropenia.
Connection Strength
0.149
-
Morita Y, Maeda Y, Yamaguchi T, Urase F, Kawata S, Hanamoto H, Tsubaki K, Ishikawa J, Shibayama H, Matsumura I, Matsuda M. Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial. Cancer Sci. 2018 Oct; 109(10):3209-3215.
Score: 0.149